BioLargo, Inc.
BLGO
$0.2088
$0.00412.00%
OTC PK
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -10.61% | -15.95% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -10.61% | -15.95% | |||
Cost of Revenue | -6.61% | -27.46% | |||
Gross Profit | -14.97% | 1.63% | |||
SG&A Expenses | -0.89% | 23.36% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -2.69% | -2.57% | |||
Operating Income | -15.22% | -52.31% | |||
Income Before Tax | -10.91% | -63.40% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -10.91% | -63.40% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | 6.69% | 37.28% | |||
Net Income | -13.91% | -88.83% | |||
EBIT | -15.22% | -52.31% | |||
EBITDA | -14.47% | -54.81% | |||
EPS Basic | -11.76% | -88.89% | |||
Normalized Basic EPS | -16.67% | -140.00% | |||
EPS Diluted | -11.76% | -88.89% | |||
Normalized Diluted EPS | -16.67% | -140.00% | |||
Average Basic Shares Outstanding | 0.02% | 0.24% | |||
Average Diluted Shares Outstanding | 0.02% | 0.24% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |